Abstract
In the last years, type 2 diabetes mellitus (T2DM) and obesity have become a serious public health problem, behaving as epidemic diseases. There is great interest in exploring different options for the treatment of T2DM in nonmorbidly obese patients. The purpose of this study is to report parameters of glycemic control in patients with T2DM and mild obesity who underwent laparoscopic Roux-en-Y gastric bypass (RYGBP). This prospective clinical trial includes patients with T2DM with a body mass index (BMI) between 30 and 35 kg/m2 who underwent laparoscopic RYGBP from July 2008 through October 2010. Thirty-one patients were included in the study, 15 men and 16 women, with an average age of 48.7 ± 8.6 years. The average time since onset of T2DM was 5.8 years. The average postoperative follow-up was 30.4 months. The average preoperative blood glucose and glycosylated hemoglobin were 152 ± 70 mg/dl and 7.7 ± 2.1 %, respectively. All of them were using oral hypoglycemic agents, and four patients were insulin dependent. Only one patient had a postoperative complication (hemoperitoneum). At 36 months follow-up, the average BMI decreased to 24.7 kg/m2, all patients (31) showed improvement in their glycemic control, and 29 of them (93.6 %) met the criteria for remission of T2DM in the last control. Laparoscopic RYGBP is a safe and effective procedure that improves glycemic control in patients with T2DM and mild obesity at midterm follow-up.
References
Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab. 2003;29:9–18.
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
Instituto Nacional de Estadisticas (National Statistics Institute, Chile). Encuesta Nacional de Salud (National Health Survey). MINSAL 2003
Donnelly R, Emslie-Smith A, Gardner I, et al. Complications of Diabetes. BMJ. 2000;320:1062–6.
Geiss L, Herman W, Smith P. Mortality in non insulin-dependent diabetes.”Diabetes in America” 2nd edition. National diabetes data group. National Health Institutes. National Institute of Diabetes and Digestive and Kidney Diseases NIH Publication. 1995;95:1468.
Haffner S, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with or without prior myocardial infarction. N Eng J Med. 1998;339:229–34.
UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPD 34). Lancet. 1998;352:854–65.
Heine R, Diamant M, Mbanya J-C, et al. Management of hyperglycemia in type 2 diabetes: the end of recurrent failure? BMJ. 2006;333:1200–4.
Dailey G, Kim M, Lian J. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res. 2002;30:71–9.
Kahn S, Haffner S, Heise M, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355:2427–43.
Dormandy J, Charbonnel B, Eckland D, et al. On behalf of the PROactive Investigators. Secondary prevention on macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366:1279–89.
Lago R, Singh P, Nesto R. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet. 2007;370:1129–36.
Parks M, Rosenbraugh C. Weighing risks and benefits of liraglutide—the FDA’s review of a new anidiabetic therapy. N Eng J Med. 2010;362:774–7.
Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236:554–9.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.
Ramos AC. Galvao Neto MP, de Souza YM, et al. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009;19:307–12.
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.
Rubino F, Schauer P, Kaplan L, et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393–411.
Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Eng J Med. 2007;357:741–52.
Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective controlled intervention trial. Lancet Oncol. 2009;10:653–62.
Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.
Christou NV, Sampalis JS, Liberman N, et al. Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24.
Csendes A, Burdiles P, Papapietro K, et al. Review of the results of medical and surgical treatment of morbid obesity. Rev Méd Chile. 2009;137:559–66.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.
Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.
Csendes A, Papapietro K, Burgos AM, et al. Efecto del by pass gástrico a largo plazo (7 a 10 años) en pacientes con obesidad severa y mórbida sobre el peso corporal, diabetes, dyslipidemia y desarrollo de anemia. Rev Med Chil. 2011;139:1423–9.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. J Am Med Assoc. 2008;299:316–23.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.
Schauer P, Kashyap S, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.
American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care. 2009;32:S13–61.
Lee W, Wang W, Lee Y, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.
DePaula A, Macedo A, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008;22:706–16.
Ramos A, Galvão M, de Souza Y, et al. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009;19:307–12.
Fried M, Ribaric J, Buchwald J, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/m2: an integrative review of early studies. Obes Surg. 2010;20:776–90.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.
Reis C, Alvarez-Leite J, Bressan J, et al. Role of bariatric–metabolic surgery in the treatment of obese type 2 diabetes with body mass index < 35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14:365–72.
Lee WJ, Yul Hur K, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16:45–62.
Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621–32.
Nguyen NT, Hinojosa M, Fayad C, et al. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg. 2007;205:248–55.
Lanzarini E, Csendes A, Lembach H, et al. Evolution of type 2 diabetes mellitus in non morbid gastrectomized patients with Roux en Y reconstruction: retrospective study. World J Surg. 2010;34:2098–102.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lanzarini, E., Csendes, A., Gutierrez, L. et al. Type 2 Diabetes Mellitus in Patients with Mild Obesity: Preliminary Results of Surgical Treatment. OBES SURG 23, 234–240 (2013). https://doi.org/10.1007/s11695-012-0780-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-012-0780-3